SuperworthFuller H B EPS FUL
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Aug 29, 2026
- $3.59
- Latest quarter, Q3 FY26
- $1.44
- +18% on a year earlier
- Fiscal year 2025
- $2.76
- +19% on the year before
Fuller H B's earnings per share was $3.59 over the twelve months to Aug 29, 2026, up 72% on a year earlier.
In its latest quarter, Q3 FY26, it was $1.44, up 18% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 3% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $2.76 | +19% |
| FY2024 | $2.31 | −11% |
| FY2023 | $2.59 | −21% |
| FY2022 | $3.26 | +10% |
| FY2021 | $2.97 | +26% |
| FY2020 | $2.36 | −6% |
| FY2019 | $2.52 | −23% |
| FY2018 | $3.29 | +191% |
| FY2017 | $1.13 | −53% |
| FY2016 | $2.42 | +43% |
| FY2015 | $1.69 | +74% |
| FY2014 | $0.97 | −49% |
| FY2013 | $1.90 | −23% |
| FY2012 | $2.47 | +38% |
| FY2011 | $1.79 | +26% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $1.44 | +18% | $3.59 | |
| Q2 FY26 | $1.23 | +62% | $3.37 | |
| Q1 FY26 | $0.38 | +58% | $2.90 | |
| Q4 FY25 | $0.54 | n/a | $2.76 | |
| Q3 FY25 | $1.22 | +24% | $2.09 | |
| Q2 FY25 | $0.76 | −16% | $1.85 | |
| Q1 FY25 | $0.24 | −56% | $2.00 | |
| Q4 FY24 | −$0.13 | −116% | $2.31 | |
| Q3 FY24 | $0.98 | +46% | $3.24 | |
| Q2 FY24 | $0.91 | +25% | $2.93 | |
| Q1 FY24 | $0.55 | +41% | $2.75 | |
| Q4 FY23 | $0.80 | −8% | $2.59 |
Against its peers
Companies in Chemicals nearest Fuller H B's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| IOSPInnospec | $4.90 | +545% a year |
| NGVTIngevity | $1.47 | |
| ROGRogers | $1.75 | |
| AVNTAvient | $1.85 | +43% a year |
| CBTCabot | $3.54 | −54% a year |
| CSWCSW Industrials | $7.29 | −13% a year |
| BCPCBalchem | $5.09 | +16% a year |
| CRONCronos | $0.20 | +300% a year |
| HXLHexcel | $1.99 | +84% a year |
| Peer median | $2.77 |
Where Fuller H B ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Fuller H B
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.